Cargando…
Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
Lurasidone is a novel antipsychotic agent approved for the treatment of schizophrenia in a number of countries including the UK, and is also approved in the USA and Canada for the treatment of major depressive episodes associated with bipolar I disorder as either a monotherapy or adjunctive therapy...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Royal College of Psychiatrists
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706192/ https://www.ncbi.nlm.nih.gov/pubmed/26755968 http://dx.doi.org/10.1192/pb.bp.114.048793 |